Pharmacological management of sleep apnea and obesity, a new frontier
- PMID: 40476603
- PMCID: PMC12320678
- DOI: 10.5664/jcsm.11798
Pharmacological management of sleep apnea and obesity, a new frontier
Conflict of interest statement
All authors have seen and approved the manuscript. The authors report no conflicts of interest.
Comment on
- Commentary on Sevencan B, Steenackers N, van Laar ADE, et al. Evaluating the potential of metabolic drugs in obstructive sleep apnea and obesity: a narrative review. J Clin Sleep Med. 2025;21(8):1433–1444. doi:10.5664/jcsm.11682
Similar articles
-
Evaluating the potential of metabolic drugs in obstructive sleep apnea and obesity: a narrative review.J Clin Sleep Med. 2025 Aug 1;21(8):1433-1444. doi: 10.5664/jcsm.11682. J Clin Sleep Med. 2025. PMID: 40114470 Review.
-
Effect of the Implementation of a Structured Diet Management Plan on the Severity of Obstructive Sleep Apnea: A Systematic Review.Curr Nutr Rep. 2023 Mar;12(1):26-38. doi: 10.1007/s13668-022-00445-w. Epub 2022 Nov 26. Curr Nutr Rep. 2023. PMID: 36435894 Free PMC article.
-
Comparison of WatchPAT to polysomnography measurement of apnea-hypopnea index and obstructive sleep apnea severity in adolescents with overweight and obesity.J Clin Sleep Med. 2025 Apr 1;21(4):695-702. doi: 10.5664/jcsm.11530. J Clin Sleep Med. 2025. PMID: 39745453
-
The efficacy of bariatric surgery on pulmonary function and sleep architecture of patients with obstructive sleep apnea and co-morbid obesity: a systematic review and meta-analysis.Surg Obes Relat Dis. 2023 Dec;19(12):1444-1457. doi: 10.1016/j.soard.2023.07.007. Epub 2023 Aug 1. Surg Obes Relat Dis. 2023. PMID: 37673709
-
Efficacy of incretin-based therapies in obesity-related obstructive sleep apnea: a systematic review and meta-analysis of randomized controlled trials.Sleep Med Rev. 2025 Aug;82:102119. doi: 10.1016/j.smrv.2025.102119. Epub 2025 Jun 17. Sleep Med Rev. 2025. PMID: 40633481 Review.
References
-
- Aronne LJ , Horn DB , Le Roux CW , et al. ; SURMOUNT-5 Trial Investigators . Tirzepatide as compared with semaglutide for the treatment of obesity [published online ahead of print, 2025. May 11]. N Engl J Med. - PubMed
LinkOut - more resources
Full Text Sources